3M Innovative Properties Company

Medicis Pharmaceutical Corporation

Other

Meda Ab

Alexis S Statham

Robert J Nelson

Leigh E Wood

David T Amos

Bathsheba E Chong Conklin

Myhanh T Truong

Michael J Svarovsky

Kevin G Lundquist

James D Stoesz

Julie M Henderson

Disposable absorbent articles comprising an absorbent material and an antimicrobial composition are disclosed. The antimicrobial composition includes a carrier comprising fatty alcohol and a poly(alkyleneoxy) polymer, and an antimicrobial agent. The antimicrobial composition may be coated on to component substrates such as nonwovens and films, that are incorporated into disposable absorbent articles, such as disposable infant diapers, adult incontinence articles, feminine hygiene articles such as sanitary napkins, wound dressings, bandages, panty liners and tampons, personal care wipes and household wipes to provide odor control, and control of microbial growth.

Antimicrobial disposable absorbent articles

A packaged composition of 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine dissolved in a fatty acid formulation and contained in a laminated packaging material having a contact layer that includes an acrylonitrile-methyl acrylate copolymer; an outer layer; and a moisture barrier layer disposed between the contact layer and outer layer.

[object Object]

Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Immune response modifier formulations containing oleic acid and methods

A pharmaceutical composition comprising 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine that is stable to sterilization and suitable for topical application directly to tissue sites where the dermis has been breached, and has been sterilized, packaged compositions that have been sterilized, and methods of sterilizing these compositions are disclosed.

Immune response modifier compositions and methods

Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation

Method of inducing cytokine biosynthesis

Method of treating actinic keratosis

Reduction of imiquimod impurities in pharmaceutical creams

Methods for stabilizing imiquimod for two months, four months, and six months

Method of controlling formation of imiquimod impurities

Method of treating basal cell carcinoma

Method of treating genital or peri-anal warts

Method of treating mollescum contagiosum

Method of reducing imiquimod impurity formation

Growing community of inventors

Woodbury, MN, United States of America

Alexis S Statham